Modulation of α-Synuclein Oligomer and Aggregate Populations by pH and Metal Ions
Abstract
1. Introduction
2. Materials and Methods
2.1. Expression and Purification of α-Syn
2.2. α-Syn Sample Preparation
2.3. Microscopy of α-Syn Mesoscale Assemblies
2.4. Dynamic Light Scattering of α-Syn Assemblies
2.5. Statistical Analysis
3. Results
3.1. pH-Dependent Emergence of Distinct α-Synuclein Assembly Regimes
3.2. Toxicity-Mitigating Compound Effects on α-Syn Oligomer Populations Depend on pH
3.3. Concentration- and pH-Dependent Modulation of α-Synuclein Assemblies by Fe3+
3.4. pH- and Concentration-Dependent Modulation of α-Syn Assemblies by Cu2+
3.5. pH-Dependent Modulation of α-Syn Assemblies by Zn2+
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Spillantini, M.G.; Crowther, R.A.; Jakes, R.; Hasegawa, M.; Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. USA 1998, 95, 6469–6473. [Google Scholar] [CrossRef] [PubMed]
- Spillantini, M.G.; Schmidt, M.L.; Lee, V.M.-Y.; Trojanowski, J.Q.; Jakes, R.; Goedert, M. Alpha-synuclein in Lewy bodies. Nature 1997, 388, 839–840. [Google Scholar] [CrossRef] [PubMed]
- Wong, Y.C.; Krainc, D. α-Synuclein toxicity in neurodegeneration: Mechanism and therapeutic strategies. Nat. Med. 2017, 23, 1–13. [Google Scholar] [CrossRef]
- Han, D.; Zheng, W.; Wang, X.; Chen, Z. Proteostasis of α-synuclein and its role in the pathogenesis of Parkinson’s disease. Front. Cell. Neurosci. 2020, 14, 45. [Google Scholar] [CrossRef]
- Bernal-Conde, L.D.; Ramos-Acevedo, R.; Reyes-Hernández, M.A.; Balbuena-Olvera, A.J.; Morales-Moreno, I.D.; Argüero-Sánchez, R.; Schüle, B.; Guerra-Crespo, M. Alpha-synuclein physiology and pathology: A perspective on cellular structures and organelles. Front. Neurosci. 2020, 13, 1399. [Google Scholar] [CrossRef]
- Brundin, P.; Melki, R. Prying into the prion hypothesis for Parkinson’s disease. J. Neurosci. 2017, 37, 9808–9818. [Google Scholar] [CrossRef]
- Volpicelli-Daley, L.A.; Brundin, P. Prion-like propagation of pathology in Parkinson disease. Handb. Clin. Neurol. 2018, 153, 321–335. [Google Scholar]
- Olanow, C.W.; Brundin, P. Parkinson’s disease and alpha-synuclein: Is Parkinson’s disease a prion-like disorder? Mov. Disord. 2013, 28, 31–40. [Google Scholar] [CrossRef]
- Hoyer, W.; Antony, T.; Cherny, D.; Heim, G.; Jovin, T.M.; Subramaniam, V. Dependence of alpha-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 2002, 322, 383–393. [Google Scholar] [CrossRef] [PubMed]
- Uversky, V.N.; Li, J.; Fink, A.L. Metal-triggered structural transformations, aggregation, and fibration of α-synuclein. J. Biol. Chem. 2001, 276, 44284–44296. [Google Scholar] [CrossRef]
- Buell, A.K.; Galvagnion, C.; Gaspar, R.; Sparr, E.; Vendruscolo, M.; Knowles, T.P.; Linse, S.; Dobson, C.M. Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation. Proc. Natl. Acad. Sci. USA 2014, 111, 7671–7676. [Google Scholar] [CrossRef] [PubMed]
- Weinreb, P.H.; Zhen, W.; Poon, A.W.; Conway, K.A.; Lansbury, P.T. NACP, a protein implicated in Alzheimer’s disease and learning, is natively unfolded. Biochemistry 1996, 35, 13709–13715. [Google Scholar] [CrossRef]
- Uversky, V.N. A protein-chameleon: Conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 2003, 21, 211–234. [Google Scholar] [CrossRef]
- Cremades, N.; Cohen, S.I.; Deas, E.; Abramov, A.Y.; Chen, A.Y.; Orte, A.; Sandal, M.; Clarke, R.W.; Dunne, P.; Aprile, F.A.; et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 2012, 149, 1048–1059. [Google Scholar] [CrossRef]
- Conway, K.A.; Harper, J.D.; Lansbury, P.T. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson’s disease are typical amyloid. Biochemistry 2000, 39, 2552–2563. [Google Scholar] [CrossRef] [PubMed]
- Conway, K.A.; Lee, S.J.; Rochet, J.C.; Ding, T.T.; Williamson, R.E.; Lansbury, P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2000, 97, 571–576. [Google Scholar] [CrossRef]
- Tokuda, T.; Qureshi, M.M.; Ardah, M.T.; Varghese, S.; Shehab, S.A.S.; Kasai, T.; Ishigami, N.; Tamaoka, A.; Nakagawa, M.; El-Agnaf, O.M.A. Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010, 75, 1766–1770. [Google Scholar] [CrossRef] [PubMed]
- Bengoa-Vergniory, N.; Roberts, R.F.; Wade-Martins, R.; Alegre-Abarrategui, J. Alpha-synuclein oligomers: A new hope. Acta Neuropathol. 2017, 134, 819–838. [Google Scholar] [CrossRef]
- Wu, K.-P.; Weinstock, D.S.; Narayanan, C.; Levy, R.M.; Baum, J. Structural reorganization of alpha-synuclein at low pH observed by NMR and REMD simulations. J. Mol. Biol. 2009, 391, 784–796. [Google Scholar] [CrossRef]
- McClendon, S.; Rospigliosi, C.C.; Eliezer, D. Charge neutralization and collapse of the C-terminal tail of alpha-synuclein at low pH. Protein Sci. 2009, 18, 1531–1540. [Google Scholar] [CrossRef]
- Dexter, D.T.; Wells, F.R.; Agid, F.; Agid, Y.; Lees, A.J.; Jenner, P.; Marsden, C.D. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987, 330, 1219–1220. [Google Scholar] [CrossRef] [PubMed]
- Wang, X.; Moualla, D.; Wright, J.A.; Brown, D.R. Copper binding regulates intracellular alpha-synuclein localisation, aggregation and toxicity. J. Neurochem. 2010, 113, 704–714. [Google Scholar] [CrossRef] [PubMed]
- Lorentzon, E.; Kumar, R.; Horvath, I.; Wittung-Stafshede, P. Differential effects of Cu2+ and Fe3+ ions on in vitro amyloid formation of biologically-relevant α-synuclein variants. BioMetals 2020, 33, 97–106. [Google Scholar] [CrossRef] [PubMed]
- Rasia, R.M.; Bertoncini, C.W.; Marsh, D.; Hoyer, W.; Cherny, D.; Zweckstetter, M.; Griesinger, C.; Jovin, T.M.; Fernández, C.O. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson’s disease. Proc. Natl. Acad. Sci. USA 2005, 102, 4294–4299. [Google Scholar] [CrossRef]
- Atarod, D.; Mamashli, F.; Ghasemi, A.; Moosavi-Movahedi, F.; Pirhaghi, M.; Nedaei, H.; Muronetz, V.; Haertlé, T.; Tatzelt, J.; Riazi, G.; et al. Bivalent metal ions induce formation of α-synuclein fibril and affect aggregation process. Sci. Rep. 2022, 12, 11898. [Google Scholar] [CrossRef]
- Al-Harthi, S.; Kharchenko, V.; Mandal, P.; Gourdoupis, S.; Jaremko, Ł. Zinc ions prevent α-synuclein aggregation by enhancing chaperone function of human serum albumin. Int. J. Biol. Macromol. 2022, 222, 2878–2887. [Google Scholar] [CrossRef]
- Mindell, J.A. Lysosomal acidification mechanisms. Annu. Rev. Physiol. 2012, 74, 69–86. [Google Scholar] [CrossRef]
- Teixeira, M.; Sheta, R.; Idi, W.; Oueslati, A. Alpha-synuclein and the endolysosomal system in Parkinson’s disease: Guilty by association. Biomolecules 2021, 11, 1333. [Google Scholar] [CrossRef]
- Mazzulli, J.R.; Zunke, F.; Isacson, O.; Studer, L.; Krainc, D. α-Synuclein–induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models. Proc. Natl. Acad. Sci. USA 2016, 113, 1931–1936. [Google Scholar] [CrossRef]
- Ferreon, A.C.; Deniz, A.A. Alpha-synuclein multistate folding thermodynamics: Implications for protein misfolding and aggregation. Biochemistry 2007, 46, 4499–4509. [Google Scholar] [CrossRef]
- Ferreon, A.C.M.; Gambin, Y.; Lemke, E.A.; Deniz, A.A. Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence. Proc. Natl. Acad. Sci. USA 2009, 106, 5645–5650. [Google Scholar] [CrossRef] [PubMed]
- Jakes, R.; Spillantini, M.G.; Goedert, M. Identification of two distinct synucleins from human brain. FEBS Lett. 1994, 345, 27–32. [Google Scholar] [CrossRef] [PubMed]
- Edelhoch, H. Spectroscopic determination of tryptophan and tyrosine in proteins. Biochemistry 1967, 6, 1948–1954. [Google Scholar] [CrossRef]
- Gill, S.C.; Von Hippel, P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 1989, 182, 319–326. [Google Scholar] [CrossRef]
- Fink, A.L. The aggregation and fibrillation of alpha-synuclein. Acc. Chem. Res. 2006, 39, 628–634. [Google Scholar] [CrossRef]
- Alam, P.; Bousset, L.; Melki, R.; Otzen, D.E. α-Synuclein oligomers and fibrils: A spectrum of species, a spectrum of toxicities. J. Neurochem. 2019, 150, 522–534. [Google Scholar] [CrossRef]
- Uversky, V.N.; Li, J.; Fink, A.L. Evidence for a partially folded intermediate in α-synuclein fibril formation. J. Biol. Chem. 2001, 276, 10737–10744. [Google Scholar] [CrossRef]
- Eliezer, D.; Kutluay, E.; Bussell, R.; Browne, G. Conformational properties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 2001, 307, 1061–1073. [Google Scholar] [CrossRef]
- Lorenzen, N.; Nielsen, S.B.; Buell, A.K.; Kaspersen, J.D.; Arosio, P.; Vad, B.S.; Paslawski, W.; Christiansen, G.; Valnickova-Hansen, Z.; Andreasen, M.; et al. The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. J. Amer. Chem. Soc. 2014, 136, 3859–3868. [Google Scholar] [CrossRef] [PubMed]
- Wagner, J.; Ryazanov, S.; Leonov, A.; Levin, J.; Shi, S.; Schmidt, F.; Prix, C.; Pan-Montojo, F.; Bertsch, U.; Mitteregger, G.; et al. Anle138b: A novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases. Acta Neuropathol. 2013, 125, 795–813. [Google Scholar] [CrossRef]
- Levin, J.; Schmidt, F.; Boehm, C.; Prix, C.; Bötzel, K.; Ryazanov, S.; Leonov, A.; Griesinger, C.; Giese, A. The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model. Acta Neuropathol. 2014, 127, 779–780. [Google Scholar] [CrossRef]
- Ehrnhoefer, D.E.; Bieschke, J.; Boeddrich, A.; Herbst, M.; Masino, L.; Lurz, R.; Engemann, S.; Pastore, A.; Wanker, E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15, 558–566. [Google Scholar] [CrossRef]
- Bieschke, J.; Russ, J.; Friedrich, R.P.; Ehrnhoefer, D.E.; Wobst, H.; Neugebauer, K.; Wanker, E.E. EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. USA 2010, 107, 7710–7715. [Google Scholar] [CrossRef] [PubMed]
- Palhano, F.L.; Lee, J.; Grimster, N.P.; Kelly, J.W. Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J. Am. Chem. Soc. USA 2013, 135, 7503–7510. [Google Scholar] [CrossRef]
- Paik, S.R.; Shin, H.-J.; Lee, J.-H.; Chang, C.-S.; Kim, J. Copper(II)-induced self-oligomerization of α-synuclein. Biochem. J. 1999, 340, 821–828. [Google Scholar] [CrossRef]
- Binolfi, A.; Rasia, R.M.; Bertoncini, C.W.; Ceolin, M.; Zweckstetter, M.; Griesinger, C.; Jovin, T.M.; Fernández, C.O. Interaction of α-synuclein with divalent metal ions reveals key differences: A link between structure, binding specificity, and fibrillation enhancement. J. Am. Chem. Soc. 2006, 128, 9893–9901. [Google Scholar] [CrossRef] [PubMed]
- Valiente-Gabioud, A.A.; Torres-Monserrat, V.; Molina-Rubino, L.; Binolfi, A.; Griesinger, C.; Fernández, C.O. Structural basis behind the interaction of Zn2+ with the protein α-synuclein and the Aβ peptide: A comparative analysis. J. Inorg. Biochem. 2012, 117, 334–341. [Google Scholar] [CrossRef] [PubMed]
- Yamin, G.; Glaser, C.B.; Uversky, V.N.; Fink, A.L. Certain metals trigger fibrillation of methionine-oxidized alpha-synuclein. J. Biol. Chem. 2003, 278, 27630–27635. [Google Scholar] [CrossRef]
- Moons, R.; Konijnenberg, A.; Mensch, C.; Van Elzen, R.; Johannessen, C.; Maudsley, S.; Lambeir, A.; Sobott, F. Metal ions shape α-synuclein. Sci. Rep. 2020, 10, 16293. [Google Scholar] [CrossRef]
- Daoud, S.; Bou-Maroun, E.; Waschatko, G.; Cayot, P. Lipid oxidation in oil-in-water emulsions: Iron complexation by buffer ions and transfer on the interface as a possible mechanism. Food Chem. 2021, 342, 128273. [Google Scholar] [CrossRef]
- Gracheva, M.; Klencsár, Z.; Homonnay, Z.; Solti, Á.; Péter, L.; Machala, L.; Novak, P.; Kovács, K. Revealing the nuclearity of iron citrate complexes at biologically relevant conditions. Biometals 2024, 37, 461–475. [Google Scholar] [CrossRef]
- Brown, P.L.; Markich, S.J. Evaluation of the free ion activity model of metal-organism interaction: Extension of the conceptual model. Aquat. Toxicol. 2000, 51, 177–194. [Google Scholar] [CrossRef] [PubMed]
- Shahmoradian, S.H.; Lewis, A.J.; Genoud, C.; Hench, J.; Moors, T.E.; Navarro, P.P.; Castaño-Díez, D.; Schweighauser, G.; Graff-Meyer, A.; Goldie, K.N.; et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 2019, 22, 1099–1109. [Google Scholar] [CrossRef] [PubMed]
- Mahul-Mellier, A.L.; Burtscher, J.; Maharjan, N.; Weerens, L.; Croisier, M.; Kuttler, F.; Leleu, M.; Knott, G.W.; Lashuel, H.A. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration. Proc. Natl. Acad. Sci. USA 2020, 117, 4971–4982. [Google Scholar] [CrossRef] [PubMed]
- Winner, B.; Jappelli, R.; Maji, S.K.; Desplats, P.A.; Boyer, L.; Aigner, S.; Hetzer, C.; Loher, T.; Vilar, M.; Campioni, S.; et al. In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. USA 2011, 108, 4194–4199. [Google Scholar] [CrossRef]






Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Nair, A.; Mitta, P.; Lucas, L.; Ferreon, J.C.; Ferreon, A.C.M. Modulation of α-Synuclein Oligomer and Aggregate Populations by pH and Metal Ions. Biomolecules 2026, 16, 326. https://doi.org/10.3390/biom16020326
Nair A, Mitta P, Lucas L, Ferreon JC, Ferreon ACM. Modulation of α-Synuclein Oligomer and Aggregate Populations by pH and Metal Ions. Biomolecules. 2026; 16(2):326. https://doi.org/10.3390/biom16020326
Chicago/Turabian StyleNair, Ananya, Punarvash Mitta, Lathan Lucas, Josephine C. Ferreon, and Allan Chris M. Ferreon. 2026. "Modulation of α-Synuclein Oligomer and Aggregate Populations by pH and Metal Ions" Biomolecules 16, no. 2: 326. https://doi.org/10.3390/biom16020326
APA StyleNair, A., Mitta, P., Lucas, L., Ferreon, J. C., & Ferreon, A. C. M. (2026). Modulation of α-Synuclein Oligomer and Aggregate Populations by pH and Metal Ions. Biomolecules, 16(2), 326. https://doi.org/10.3390/biom16020326

